NSABP PROTOCOL B-51
RTOG PROTOCOL 1304
A RANDOMIZED PHASE III CLINICAL TRIAL EVALUATING POST-MASTECTOMY CHESTWALL AND REGIONAL NODAL XRT AND POST-LUMPECTOMY REGIONAL NODAL XRT IN PATIENTS WITH POSITIVE AXILLARY NODES BEFORE NEOADJUVANT CHEMOTHERAPY WHO CONVERT TO PATHOLOGICALLY NEGATIVE AXILLARY NODES AFTER NEOADJUVANT CHEMOTHERAPY
RTOG PROTOCOL 1304
A RANDOMIZED PHASE III CLINICAL TRIAL EVALUATING POST-MASTECTOMY CHESTWALL AND REGIONAL NODAL XRT AND POST-LUMPECTOMY REGIONAL NODAL XRT IN PATIENTS WITH POSITIVE AXILLARY NODES BEFORE NEOADJUVANT CHEMOTHERAPY WHO CONVERT TO PATHOLOGICALLY NEGATIVE AXILLARY NODES AFTER NEOADJUVANT CHEMOTHERAPY
Protocol Participation Information
- Credentialing
- Facility Questionnaire: Part I and Part II are required for this protocol.
- Download fillable forms and complete them.
- Submit to RTOG RT Quality Assurance Department
Email: rtog-facquest@phila.acr.org &nbps; Fax: 215-940-8817
- Benchmark: please see the RPC web site for benchmark requiements
- Facility Questionnaire: Part I and Part II are required for this protocol.
- How to Participate
- Digital Data Submission Procedures
- Digital Data Submission Information (DDSI) Form
- Submission Check list
- ATC Compliant Treatment Planning Systems
- Structure Names (in preparation)
- Protocol Information (http://www.rtog.org/)
Back to protocols
